Pharmacogenomic approaches that may guide preeclampsia therapy

By Luizon Marcelo R   Sandrim Valeria C  

Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. : 591-593

Future Medicine

Access to resources Recommend Favorite

Cyanobacteria as a Source for Novel Anti-Leukemic Compounds

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 78-91

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 17, 2015-06 ,pp. : 2065-2074

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 30-47

Bentham Science Publishers

Access to resources Recommend Favorite

Stereochemistry as a Determinant of the Anti-Leukemic Potency of Halopyridyl and Thiazolyl Thiourea Compounds

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 5, 2007-07 ,pp. : 318-326

Bentham Science Publishers

Access to resources Recommend Favorite